Skip to main content
2024 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Listen Now

Formulation and Delivery
Partner Presentation

Optimizing Drug Delivery Strategies in Phase 1 Oral Development Through Developability Assessment

Monday, October 21, 2024
12:30 PM – 1:30 PM MT
Location:360 Stage #4, Exhibit Hall

Sponsored By 
Formulation and Delivery Partner Presentation-Formulation

    Partner Presentation Speaker(s)

  • Lisa Caralli, B.S.

    Sr. Director, Scientific Advisory
    Catalent
    San Diego, California

Description: Achieve Phase 1 clinical trial success by leveraging expert guidance from dedicated scientific advisory, accelerated development and manufacturing timelines as well as minimal API usage. This presentation offers comprehensive strategies to streamline development through developability assessments, PBPK modeling, and addressing formulation challenges, all aimed at enhancing Phase 1 readiness and ensuring clinical success.

Learning Objectives:

  • Explore strategies to expedite Phase 1 readiness with minimal resources (time, API, funding).
  • Understand how preformulation and PBPK modeling optimize small molecule developability assessments.
  • Learn how Catalent's experts define problem statements to refine the assessment of formulation technology, thereby identifying issues at an early stage to mitigate risks within clinical program.